Related Experiment Video

Updated: Oct 10, 2025

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

18.3K

"Very Compelling" Results for ADC in TNBC Trial

    Cancer Discovery
    |December 16, 2021
    PubMed

    Abstract:

    In a phase I trial, the antibody-drug conjugate datopotamab deruxtecan demonstrated encouraging response rates and manageable toxicity in patients with advanced/metastatic triple-negative breast cancer that has recurred after, or is resistant to, multiple therapies. Overall, 34% of patients experienced a complete or partial response.

    More Related Videos

    Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
    13:19

    Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

    Published on: April 26, 2024

    3.0K
    High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds
    13:59

    High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds

    Published on: August 18, 2023

    2.3K

    Related Experiment Videos

    Last Updated: Oct 10, 2025

    Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
    09:29

    Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

    Published on: March 20, 2020

    18.3K
    Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
    13:19

    Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

    Published on: April 26, 2024

    3.0K
    High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds
    13:59

    High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds

    Published on: August 18, 2023

    2.3K

    Related Concept Videos

    Treatment Resistant Cancers02:56

    Treatment Resistant Cancers

    3.4K
    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
    3.4K

    Articles linked to this work by shared authors, journal, and citation graph.

    AI Model Predicts Cancer Development, Diagnoses Tumors.

    Cancer discovery·2026

    In Regulatory First, Myeloma Drug Approved Based on MRD Negativity.

    Cancer discovery·2026

    Transmissible Cancer Discovered in Catfish.

    Cancer discovery·2026

    Follicular Lymphoma Transformation is Characterized by Cytokine-associated Remodeling of Stromal and Macrophage Compartments.

    Cancer discovery·2026

    Genomics of Subsequent Neoplasms in Childhood Cancer Survivors.

    Cancer discovery·2026

    A Counterintuitive Approach to Cancer Therapy.

    Cancer discovery·2026

    Uncoupling Type I Interferon Benefits From Inflammatory Toxicity: Transformer-Prioritized Precision Agonists for Potent and Safer Cancer Immunotherapy.

    Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

    Elacestrant in Combination with Everolimus for Estrogen Receptor-Positive, HER2-Negative Previously Treated Advanced Breast Cancer: Results from ELEVATE.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2026

    Association between ineffective health self-management and severe radiodermatitis: Cohort study.

    International journal of nursing knowledge·2026

    Systematic review: Stereotactic Body Radiation Therapy for Pancreatic Cancer: Evaluating its Efficacy, Safety, and Future Prospects.

    The British journal of radiology·2026

    A prospective, randomized study comparing different therapeutic modalities for acute adenoviral conjunctivitis.

    Indian journal of ophthalmology·2026

    Laser and Light-Based Therapies in Inflammatory Dermatoses: A Systematic Review of Safety, Efficacy, and Adverse Effects to Inform Cosmetic Use.

    Lasers in surgery and medicine·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us